Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Patient safety

BBC investigation prompts reminder on fire risk warning for skin creams

MHRA highlights advice for healthcare professionals after a radio programme claims there were 37 fire deaths in England associated with paraffin-containing skin creams during 2010.

Close up of cream labels that include paraffin

Source: MAG / The Pharmaceutical Journal

The MHRA has reiterated that the labelling of any emollient that is authorised as a medicine should include the appropriate warning advising of the risk from fire

Healthcare professionals have been reminded of the fire risk associated with paraffin-containing skin creams, following a BBC radio programme that highlighted the potential dangers.

An investigation by BBC Radio 5 Live, which was aired on 19 March 2017, claimed that there had been 37 fire deaths in England associated with paraffin-containing skin creams since 2010.

The programme prompted the UK Medicines and Healthcare products Regulatory Agency (MHRA), which regulates medicines and medical devices in the UK, to highlight the advice it has given healthcare professionals about the potential fire risks linked to paraffin-containing skin products.

The MHRA also reiterated that it has requested that manufacturers include appropriate warnings on their products.

A spokesperson for the MHRA says: “For those emollients which are licensed as medicinal products we have asked that they all carry a warning to alert patients, carers and healthcare professionals to the risk from fire.

“We have advised healthcare professionals through articles in our monthly Drug Safety Update publication of these risks on two occasions in 2008 and again in 2016.”

The MHRA says that, following the results of a study by the National Patient Safety Agency in 2007, it wrote to marketing authorisation holders in 2008 requesting that emollients authorised as medicinal products which contained 50% or more of a paraffin base should carry a warning advising of the risk from fire.

However, the MHRA spokesperson acknowledges that “there is no legal requirement for companies to action this”.

“This advice has now been updated and where any emollient is authorised as a medicine the expectation is that the labelling will include the appropriate warning advising of the risk from fire,” they add.

The Proprietary Association of Great Britain (PAGB), the UK trade association representing manufacturers of branded over-the-counter medicines, sought to reassure the public about the safety of paraffin-containing skin creams.

It issued a statement after the BBC Radio investigation aired, pointing out that the fire risks relating to emollients are associated with them being used in “significant amounts” of 100g or more, which would typically take place in a healthcare setting rather than use in the home “by people treating common levels or eczema or other dry skin conditions”.

John Smith, chief executive of the PAGB, says: “We want to reassure people that the normal use of emollients in the home is considered appropriately safe provided the products are used in accordance with the on-pack instructions and accompanying patient information leaflet.

“Manufacturers of emollients are not at present required by regulation or statute to include fire safety warnings on packaging.”

He adds: “In the light of this investigation, [the] PAGB is looking to explore this issue further with the member companies and relevant bodies to see if in future, safety warnings should be added to on-pack labelling for all paraffin-based emollients as standard practice across the industry, a step which some manufacturers have already taken.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20202492

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Close up of cream labels that include paraffin

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.